ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 53 filers reported holding ALIGOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,145,000 | -9.1% | 1,950,000 | 0.0% | 0.10% | -12.1% |
| Q2 2022 | $2,360,000 | -43.7% | 1,950,000 | 0.0% | 0.12% | -47.5% |
| Q1 2022 | $4,193,000 | -86.5% | 1,950,000 | -25.4% | 0.22% | -85.0% |
| Q4 2021 | $31,035,000 | -23.5% | 2,614,563 | 0.0% | 1.47% | -30.0% |
| Q3 2021 | $40,552,000 | -23.9% | 2,614,563 | 0.0% | 2.10% | -11.3% |
| Q2 2021 | $53,311,000 | -10.3% | 2,614,563 | 0.0% | 2.36% | -3.7% |
| Q1 2021 | $59,455,000 | -17.8% | 2,614,563 | 0.0% | 2.46% | -20.8% |
| Q4 2020 | $72,293,000 | – | 2,614,563 | – | 3.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $2,028,013 | 4.23% |
| TANG CAPITAL MANAGEMENT LLC | 3,424,800 | $2,993,275 | 0.45% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $649,570 | 0.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $552,269 | 0.23% |
| Vivo Capital, LLC | 3,547,030 | $3,100,104 | 0.22% |
| Newtyn Management, LLC | 1,021,461 | $892,757 | 0.18% |
| Logos Global Management LP | 1,000,000 | $874,000 | 0.12% |
| EcoR1 Capital, LLC | 3,948,360 | $3,450,867 | 0.11% |
| HHLR ADVISORS, LTD. | 2,309,764 | $2,018,734 | 0.04% |
| Baker Brothers Advisors | 2,076,400 | $1,814,774 | 0.01% |